Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Malignant Melanoma

  Free Subscription


19.10.2026

1 BMC Cancer
1 Cancer Res
1 Eur J Dermatol
2 J Am Acad Dermatol
1 J Clin Invest
1 J Immunol
1 Ophthalmology


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    BMC Cancer

  1. GUPTA MK, Zoabi R, Yado S, Starruss J, et al
    Decoupling T cell cytotoxicity: a CCL21+ICAM1-based synthetic immune niche enhances tumor elimination by accelerating lytic hit delivery.
    BMC Cancer. 2026;26:1235.
    PubMed         Abstract available


    Cancer Res

  2. HSU CH, Chen J, Donahue LR, Lee KJ, et al
    Regression-Associated Macrophages Recruit Natural Killer Cells That Constrain Targeted Therapy Resistance.
    Cancer Res. 2026;86:5130-5146.
    PubMed         Abstract available


    Eur J Dermatol

  3. GUIRONNET B, Allix-Beguec C, Celerier P, Frenard C, et al
    AI-based melanoma assisted diagnosis in primary care: a prospective real-world study.
    Eur J Dermatol. 2026;36:467-468.
    PubMed        


    J Am Acad Dermatol

  4. TRAN HTT, Shrestha R, Le DV, Dang LT, et al
    Response to De Giorgi et al., "Surgical delay in early-stage vulvar melanoma: caution in defining a causal threshold.".
    J Am Acad Dermatol. 2026 Oct 16:S0190-9622(26)03750.
    PubMed        

  5. DE GIORGI V, Perillo G, Cecchi G, Fazzari F, et al
    Surgical delay in early-stage vulvar melanoma: caution in defining a causal threshold.
    J Am Acad Dermatol. 2026 Oct 15:S0190-9622(26)03751.
    PubMed        


    J Clin Invest

  6. THEIVANTHIRAN B, Yarla N, Villarreal K, Nguyen YV, et al
    Tumor NLRP3 amplification promotes immunotherapy resistance by inhibiting STAT1 signaling and MHC class I expression.
    J Clin Invest. 2026;136:e201816.
    PubMed         Abstract available


    J Immunol

  7. HOLCOMB EA, Jiang L, Pearson AN, James J, et al
    CRISPR-Cas9 screen identifies eIF4G2 as a regulator of CD8+ T cell dysfunction.
    J Immunol. 2026;215:vkag187.
    PubMed         Abstract available


    Ophthalmology

  8. LABKOVICH M, Finger PT
    The Second and Third Decade After 103Pd Plaque Brachytherapy for Choroidal Melanoma.
    Ophthalmology. 2026 Oct 14:S0161-6420(26)00779.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum